BCR 2016 214442
BCR 2016 214442
BCR 2016 214442
CASE REPORT
Poppers retinopathy
Joshua Luis, Meena Virdi, Shahriar Nabili
by copyright.
thalmology acute referral clinic with a 10-day trolled under the Misuse of Drugs Act2 and are
history of central visual blurring and metamor- therefore readily available from a variety of
phopsia. He reported normal peripheral vision, sources.
and had no other visual symptoms of note. The Despite the high prevalence of poppers, there
deterioration was noted immediately following a have only been around 30 published cases of
night of clubbing, during which time the patient poppers retinopathy/maculopathy. The actual inci-
inhaled ‘poppers’ for the first time. He was HIV dence is likely to be much higher, although the
negative and systemically well. majority of these are asymptomatic.3 All cases
Slit-lamp examination was unremarkable, with present with bilaterally symmetrical central field
normal fundal views. His best corrected visual loss or distortion, with preservation of peripheral
acuity was 6/15 in the left eye and 6/12 in the fields. Other symptoms such as loss in colour
right, improving to 6/12 and 6/9.5, respectively, vision, photopsias and positive scotomas are more
with pinhole. His pupil reactions and colour vision variable.4–6
were normal. Spectral domain optical coherence SD-OCT provides the most valuable diagnostic
tomography (SD-OCT) showed disruption of the test, showing pathognomonic disruption of the
inner and outer segment layers, confined to the inner and outer segment layers in both foveae.7–9
fovea. These findings were identical in both eyes Fundus fluorescein angiograms (FFAs), when
(figure 1). carried out, are invariable normal.
The patient was treated conservatively, with The SD-OCT findings are similar to those
advice regarding cessation of drug use. At 3 months observed in photic injury.10 However, some recent
follow-up, the patient’s best corrected visual acuity cases have shown abnormalities in full-field
improved marginally to 6/9.5 bilaterally. OCT
showed improvement in the photoreceptor layer,
although some mild changes in the foveal area
remained (figure 2).
DIFFERENTIAL DIAGNOSIS
Differential diagnoses for poppers retinopathy
include photic injury, central serous retinopathy
To cite: Luis J, Virdi M,
Nabili S. BMJ Case Rep
and vitreoretinal traction. Photic injury can gener-
Published online: [please ally be differentiated by history, while other condi-
include Day Month Year] tions are all very unlikely to present symmetrically.
doi:10.1136/bcr-2016- This therefore highlights the importance of relevant
214442 drug history and examining both eyes. Figure 2 Improvement at 3 months follow-up.
Luis J, et al. BMJ Case Rep 2016. doi:10.1136/bcr-2016-214442 1
BMJ Case Reports: first published as 10.1136/bcr-2016-214442 on 7 March 2016. Downloaded from http://casereports.bmj.com/ on 12 August 2021 at Cote d'Ivoire:BMJ-PG Spon. Protected
Rare disease
electroretinography.5 This supports the presence of diffuse tening control over substances similar to and including poppers,
retinal damage, and is not limited to the maculae as previously in the UK.
thought. The current proposed mechanism of injury for
poppers is that of free radical release from the nitrite chemi- Competing interests None declared.
cals.3 11 As a consequence, these studies advocate the use of the Patient consent Obtained.
term ‘poppers retinopathy’ over ‘poppers maculopathy’.12 Provenance and peer review Not commissioned; externally peer reviewed.
In poppers retinopathy, disease progression is successfully
halted following abstinence from the substance in all cases. REFERENCES
Recovery is variable, with some patients achieving complete 1 Gruener AM, Jeffries MA, El Housseini Z, et al. Poppers maculopathy. Lancet
2014;384:1606.
resolution while others experience no improvement. There is no
2 Davies AJ, Kelly SP, Naylor SG, et al. Adverse ophthalmic reaction in poppers users:
current proven therapy, however, there are reports of oral lutein case series of ‘poppers maculopathy’. Eye (Lond) 2012;26:1479–86.
therapy, which may be of benefit.6 The incidence of poppers ret- 3 Schulze-Döbold C, Ben Denoun M, Dupas B, et al. Retinal toxicity in users of
inopathy does not appear to be dose related,13 furthermore, “poppers.” Ann Intern Med 2012;156(9):670–2.
there is no current evidence to suggest that patient demograph- 4 Audo I, El Sanharawi M, Vignal-Clermont C, et al. Foveal damage in habitual
poppers users. Arch Ophthalmol 2011;129:703–8.
ics or HIV status have any influence. 5 Savary P, Biotti D, Abouaf L, et al. Poppers toxic maculopathy misdiagnosed as
At the time of writing, the ‘Psychoactive Substances Bill’ is at atypical optic neuritis. Eur J Neurol 2013;20:e90–1.
the report stage during its progress through the House of 6 Pahlitzsch M, Draghici S, Mehrinfar BM. [Poppers-associated maculopathy].
Commons. This new set of legislations has the intention of tigh- Klin Monbl Augenheilkd 2013;230:727–32.
7 Asensio-Sánchez VM, Gonzalez-Buendia L, Marcos-Fernández M. Maculopathy due
to drug inhalation. Arch Soc Esp Oftalmol 2014;89:313–15.
8 Bruninx R, Lepiece G. Didactic image poppers maculopathy. Bull Soc Belge
Learning points Ophtalmol 2013(322):133–5.
9 Rabot A, Pinon F, Baillif S. [SD-OCT appearance in acute poppers-associated
macular toxicity]. J Fr Ophtalmol 2013;36:388–9.
▸ Drug and sexual history can be of crucial importance in the 10 Fajgenbaum MA. Is the mechanism of ‘poppers maculopathy’ photic injury?
investigation of visual disturbances. Eye (Lond) 2013;27:1420–1.
11 Vignal-Clermont C, Audo I, Sahel JA, et al. Poppers-associated retinal toxicity.
▸ Poppers retinopathy presents as bilateral, symmetrical, N Engl J Med 2010;363:1583–5.
central visual disturbances. 12 Clemens CR, Alten F, Loos D, et al. Poppers maculopathy or retinopathy?
▸ Stopping the usage of poppers terminates worsening of Eye (Lond) 2015;29:148–9.
symptoms, however, recovery is variable. 13 Davies AJ, Kelly SP, Bhatt PR. ‘Poppers maculopathy’—an emerging ophthalmic
reaction to recreational substance abuse. Eye (Lond) 2012;26:888.
by copyright.
Copyright 2016 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit
http://group.bmj.com/group/rights-licensing/permissions.
BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.